2024 CME Information

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and North American Neuro-Ophthalmology Society (NANOS). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

HOW TO CLAIM CME FOR THE NANOS IN-PERSON MEETING:
The NANOS 50th Annual Meeting is approved for up to 33 AMA PRA Category 1 Credits™. If you forgot to claim your CME certificate for the in-person event, please click HERE.

HOW TO CLAIM CME FOR THE NANOS ON-DEMAND MEETING:

The NANOS 50th Annual Meeting is approved for up to 33 AMA PRA Category 1 Credits™. 

Between April 10th and August 31st, 2024 please click here to complete the NANOS 2024 on-demand meeting evaluation and claim your CME credits for the NANOS 2024 on-demand meeting.

2024 NANOS On-Demand Meeting Evaluation (DEADLINE: AUGUST 31st, 2024)

MAINTENANCE OF CERTIFICATION (MOC) PRE & POST TEST
Medical Education Resources (MER) designates the NANOS 50th Annual Meeting live activity for a maximum of 33 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME credits are jointly provided by MER and the North American Neuro-Ophthalmology Society (NANOS). If claiming Self-Assessment Maintenance of Certification (MOC) credits, you must complete the Pre-Test and Post-Test and self-report this data to ABPN/ABO as it is separate from ACCME reporting.

Complete your MOC Pre-Test

Complete your MOC Post Test

Total Annual Meeting Credits: 33 AMA PRA Category 1 Credits™ 

ABPN Self-Assessment CME 
The American Board of Psychiatry and Neurology has reviewed the 2024 NANOS Annual Meeting and has approved this activity as part of a comprehensive Self-Assessment (SA) CME activity, which is managed by the ABMS as a necessary component of continuing certification. More information can be found at www.abpn.com.  

ABO Self-Assessment CME 
As of 2023, American Board of Ophthalmology (ABO) is no longer participating in the ACCME collaboration. We are no longer able to upload ABO credit directly through the ACCME site. Diplomats will self-report and attest to the amount of credit they claim when submitting credit. CME activities which include participation in a pre/post knowledge evaluation component, earn credit towards the Lifelong Learning Self-Assessment requirement for the ABO's Continuing Certification program. More information can be found at www.abop.org.  

STATEMENT OF NEED
The purpose of the North American Neuro-Ophthalmology Society’s Continuing Medical Education (CME) program is to present neuro-ophthalmologists with quality lifelong learning opportunities to promote improvement and change in physician practices, performance, and competence needed to provide the best possible neuro-ophthalmic care for their patients.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:

• Identify recent advances in the diagnosis and treatment of neuro-ophthalmic diseases.
• Identify advances in key areas of cutting-edge research and technology in neuro-ophthalmology.
• Apply skills and techniques from the educational sessions into their daily practice. 

MISSION STATEMENT
The North American Neuro-Ophthalmology Society (NANOS) is dedicated to achieving inclusive excellence in the care of patients with neuro-ophthalmic diseases by the support and promotion of equitable education, research, and the practice of Neuro-Ophthalmology.

TARGET AUDIENCE
This activity has been designed to meet the educational needs of neuro-ophthalmologists (neurologists and ophthalmologists) involved in the care of patients with neuro-ophthalmic disorders.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

DISCLOSURE OF UNLABELED/UNAPPROVED USES
This educational program may include references to the use of products for indications not approved by the FDA. Areas of unapproved uses will be disclosed at each presentation. Opinions expressed with regards to unapproved uses of products are solely those of the faculty and are not endorsed by Medical Education Resource or the North American Neuro-Ophthalmology Society or any other manufacturers of pharmaceuticals.

CREDIT DESIGNATION
Medical Education Resources designates this live activity for a maximum of 33 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Jointly provided by Medical Education Resources and the North American Neuro-Ophthalmology Society.

DISCLAIMER
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or NANOS. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources or NANOS. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Jointly provided by Medical Education Resources and the North American Neuro-Ophthalmology Society.